Does MIRABEGRON Cause Agranulocytosis? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Agranulocytosis have been filed in association with MIRABEGRON (MIRABEGRON). This represents 0.1% of all adverse event reports for MIRABEGRON.
10
Reports of Agranulocytosis with MIRABEGRON
0.1%
of all MIRABEGRON reports
6
Deaths
6
Hospitalizations
How Dangerous Is Agranulocytosis From MIRABEGRON?
Of the 10 reports, 6 (60.0%) resulted in death, 6 (60.0%) required hospitalization.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRABEGRON. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which MIRABEGRON Alternatives Have Lower Agranulocytosis Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE